Technology Overview
HµREL® Corporation provides proprietary co-cultures and patented microfluidic devices that elevate the cellular responsiveness, metabolic competency, and endurance of cells cultured in vitro, and that simulate pharmacokinetic interactions among multiple tissues and organs. These proprietary capabilities produce unrivaled levels of physiologically relevant predictive sensitivity—”human relevance.”
U.S. Patent No’s. 5,612,188; 7,288,405; 8,030,061; other patents pending